| prenatal drug exposure |
drug |
2 |
2 |
|
| Prenatal nicotine exposure |
drug |
2 |
1 |
prenatal nicotine exposure |
| prenatal stress |
phenotype |
2 |
2 |
|
| pre-phasing |
drug |
2 |
2 |
|
| prepulse inhibition |
phenotype |
5 |
2 |
PPI |
| preregistered phenotypes |
phenotype |
2 |
2 |
|
| presenilin |
gene |
2 |
1 |
PSEN1, PSEN2, presenilins |
| present study |
cohort |
10 |
4 |
current study |
| pressure pain threshold |
phenotype |
3 |
3 |
pressure pain thresholds |
| preterm birth |
phenotype |
7 |
2 |
pre-term birth |
| primary antibody |
drug |
3 |
1 |
|
| primary biliary cirrhosis |
phenotype |
2 |
1 |
PBC |
| primary care |
cohort |
3 |
3 |
primary care sources |
| principal components |
drug |
3 |
5 |
PC, PC1, PC2, PCs |
| principal neurons |
phenotype |
2 |
2 |
novel principal neurons |
| prison inmates |
cohort |
2 |
— |
|
| PRKACA |
gene |
4 |
1 |
PKA, PKA catalytic subunit, protein kinase A |
| PRKAR2A |
gene |
2 |
2 |
PKA regulatory RIIα subunit |
| PRKCA |
gene |
5 |
3 |
PKC, PKCα, protein kinase C |
| PRKCB |
gene |
2 |
2 |
PKCβ |
